wire - news in brief


Category



Results 151 - 200 of 395.


Pharmacology - Innovation - 14.10.2019
A smart speaker helps care for the elderly at home
A smart speaker helps care for the elderly at home
Two students from EPFL have developed a smart speaker with voice-activation technology that connects patients directly to their loved ones as well as caregivers and emergency services.

Electroengineering - Music - 14.10.2019
"I teach a subject that's notoriously hard to learn"
Romain Fleury, a tenure-track assistant professor who heads the Laboratory of Wave Engineering, has been named best teacher in electrical and electronic engineering.

Chemistry - Materials Science - 14.10.2019
From the Walkman to the electric car
From the Walkman to the electric car
Three researchers share this year's Nobel Prize in Chemistry. They are being honoured for their respective contributions in research that led to today's rechargeable lithium-ion batteries - and has made our smartphones and electric cars possible in their current form.

Pharmacology - Health - 14.10.2019
Roche’s MabThera/Rituxan (rituximab) superior to mycophenolate mofetil in patients with pemphigus vulgaris
40% of patients with pemphigus vulgaris (PV) achieved sustained complete remission, without the use of steroids for 16 weeks or more, when treated with MabThera/Rituxan compared to 9.5% of pat

Innovation - Agronomy / Food Science - 11.10.2019

Business / Economics - Materials Science - 11.10.2019
Using industrial waste as insulation for buildings
Using industrial waste as insulation for buildings
ETH spinoff FenX transforms industrial waste into a porous foam suitable for building insulation. Unlike other sustainable materials used for the purpose, this type of insulation is non-flammable and inexpensive to produce.

Health - Life Sciences - 11.10.2019
ERC Synergy Grant for research at the interface of viral infection and cellular regulation
ERC Synergy Grant for research at the interface of viral infection and cellular regulation
The European Research Council has awarded one of the prestigious ERC Synergy Grants - the most competitive funding scheme from ERC - to a joint research project of the Friedrich Miescher Institute for Biomedical Research, the ETH Zurich and the University of Bristol. The interdisciplinary team wants to investigate the molecular mechanisms of viral infection, which will contribute to fundamental knowledge about cellular regulation and new concepts for broad-spectrum anti-viral therapy.

Health - Life Sciences - 11.10.2019
ERC Synergy Grant for viral infection and cellular regulation research
The European Research Council has awarded one of the prestigious ERC Synergy Grants - the most competitive funding scheme from ERC - to a joint research project of the Friedrich Miescher Institute for Biomedical Research, the ETH Zurich and the University of Bristol. The interdisciplinary team wants to investigate the molecular mechanisms of viral infection, which will contribute to fundamental knowledge about cellular regulation and new concepts for broad-spectrum anti-viral therapy.

Computer Science / Telecom - 10.10.2019
Bike designed with artificial intelligence breaks world speed records
Bike designed with artificial intelligence breaks world speed records
An aerodynamic bike that was designed using software from Neural Concept, a spin-off from the Computer Vision Laboratory (CVLab) in the EPFL School of Computer and Communication Sciences, has broken two world records for cycling speed.

Life Sciences - 09.10.2019
Details of Dental Wear Revealed
The teeth of mammals experience constant wear. However, the details of these wear processes are largely unknown. Researchers at the University of Zurich have now demonstrated that the various areas of herbivores' teeth differ in how susceptible they are to dental wear, detailing an exact chronology.

Architecture - 08.10.2019
A new anthology highlights the legacy of Rem Koolhaas
A new anthology highlights the legacy of Rem Koolhaas
"I regard myself as a descendent of the true Modernists," a young Rem Koolhaas told Dutch journal wonen-TA/BK in 1978.

Materials Science - 08.10.2019

Health - Life Sciences - 08.10.2019
Prostate cancer research, important SNF grant goes to the IOR
The Prostate cancer biology Group, led by Dr. Giuseppina Carbone at the Institute of Oncology Research (IOR, affiliated to USI Università della Svizzera italiana), has received a 4-year grant

Event - Life Sciences - 08.10.2019

Pharmacology - Health - 08.10.2019
Novartis receives FDA approval for Beovu , offering wet AMD patients vision gains and greater fluid reductions vs aflibercept
In two head-to-head clinical trials, patients on Beovu (brolucizumab) achieved vision gains that were non-inferior to aflibercept at year one with longer treatment intervals in a majority of patients

Electroengineering - Business / Economics - 07.10.2019
Built-in expiry date
Built-in expiry date
Whether mobile phone or automatic toilets - electronic devices are becoming increasingly complex. And who hasn't heard stories of devices that fail precisely after the warranty has expired?

Career - Materials Science - 07.10.2019

Innovation - Computer Science / Telecom - 07.10.2019
Deep learning, prefabricated
Deep learning, prefabricated
Self-driving cars, the automatic detection of cancer cells, online translation: deep learning makes it all possible. The ETH spin-off Mirage Technologies has developed a deep learning platform that aims to help start-ups and companies more quickly develop and optimise their products. The name has a fairytale feel to it, with its reference to mirages and the suggestion of illusion.

Pharmacology - Life Sciences - 05.10.2019
AveXis presents updated STRONG data at WMS demonstrating a higher mean increase in Hammersmith Functional Motor Scale-Expanded (HFMSE) scores among older SMA Type 2 patients following one-time intrathecal administration of AVXS-101
Older patients (= 2 years and < 5 years) achieved a mean increase of 5.9 points from baseline in HFMSE scores, nearly double the clinically meaningful threshold (at a mean duration of follo

Astronomy / Space Science - Environment - 04.10.2019
Taking sustainability into space
Things are changing in outer space: it is filling with debris, attracting private companies, and raising new technological challenges.

Computer Science / Telecom - Career - 03.10.2019
New Microsoft research laboratory collaborates with ETH Zurich
New Microsoft research laboratory collaborates with ETH Zurich
These days, Microsoft officially opens a lab in Zurich dedicated to researching mixed reality technologies and artificial intelligence.

Linguistics / Literature - 03.10.2019
The urban writer
The urban writer
Marc Angélil played a decisive role in shaping the teaching of architecture at ETH Zurich, both as professor and as temporary head of the department.

Pharmacology - Health - 02.10.2019
Novartis positive 52-week PREVENT data confirm Cosentyx efficacy in addressing entire axSpA spectrum
Phase III PREVENT study met 52-week primary endpoint of ASAS40, showing a sustained response in patients with non-radiographic axial spondyloarthritis (nr-axSpA)   Novartis plans FDA submission for nr-axSpA, having submitted to EMA previously.

Pharmacology - Health - 01.10.2019
Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence
Multiyear alliance underpins the Novartis commitment to leverage data & Artificial Intelligence (AI) to transform how medicines are discovered, developed and commercialized Novartis to establish

Pharmacology - Health - 30.09.2019
Roche presents positive Phase III results for Tecentriq (atezolizumab) in combination with platinum-based chemotherapy in people with previously untreated advanced bladder cancer
Roche presents positive Phase III results for Tecentriq (atezolizumab) in combination with platinum-based chemotherapy in people with previously untreated advanced bladder cancer IMvigor130 is the fi

Health - Life Sciences - 30.09.2019
Young USI researchers on stage at the first Ph.D Biomed Day
Young USI researchers on stage at the first Ph.D Biomed Day
They are 16, determined and ready to dive into the exciting world of research: the first Ph.D students from the new USI Faculty of Biomedical Sciences presented themselves on Friday 20 September at t

Pharmacology - Health - 30.09.2019
Novartis announces positive results from Phase III PALLADIUM study of inhaled combination QMF149 in patients with uncontrolled asthma
Once-daily QMF149 demonstrated superior improvement in lung function versus mometasone furoate, meeting primary endpoint PALLADIUM is part of Phase III PLATINUM clinical development program, which ev

Health - Pharmacology - 30.09.2019
Roche to present results of first prospective trial using blood-based next generation sequencing which successfully identifies people for treatment with Alecensa
Efficacy of Alecensa (alectinib) in people identified to have ALK-positive non-small cell lung cancer using liquid biopsy is consistent with efficacy in those identified by tissue analysis in the pivotal Phase III ALEX study Roche will today announce positive results from a single-arm cohort of the Phase II/III Blood First Assay Screening Trial (BFAST), the first prospective study to use only blood-based next generation sequencing (NGS) to detec

Pharmacology - Health - 30.09.2019
Novartis announces positive results from Phase III IRIDIUM study of inhaled combination QVM149 in patients with uncontrolled asthma
Once-daily QVM149 demonstrated statistically significant improvement in lung function versus QMF149, meeting primary endpoint ,   IRIDIUM is largest study in Phase III PLATINUM clinical development p

Pharmacology - Health - 30.09.2019
FDA approves Roche’s Rituxan (rituximab) in children with two rare blood vessel disorders
Rituxan is the first and only FDA-approved treatment for paediatric patients 2 years of age and older living with granulomatosis with polyangiitis or microscopic polyangiitis These two forms of vascu

Pharmacology - Health - 29.09.2019

Pharmacology - Health - 28.09.2019
Roche to present new and updated data at ESMO 2019 reinforcing the use of Alecensa in the first-line setting for advanced ALK-positive non-small cell lung cancer
New real-world data from the Flatiron database supports clinical benefits of Alecensa (alectinib) across time to treatment discontinuation, real-world progression free survival and overall survival F

Pharmacology - Health - 27.09.2019
Roche’s Tecentriq improves overall survival as a first-line monotherapy in certain people with advanced non-small cell lung cancer
Phase III IMpower110 study showed Tecentriq monotherapy helped people with advanced non-small cell lung cancer (NSCLC) with high PD-L1 expression live longer compared with chemotherapy alone Data wil

Pharmacology - Health - 27.09.2019
Roche’s Tecentriq in combination with Avastin shows encouraging results in Phase Ib study of people with unresectable hepatocellular carcinoma
The study showed a confirmed objective response rate of 36% for people treated with the Tecentriq and Avastin combination in unresectable hepatocellular carcinoma who have not received prior systemic

Environment - Life Sciences - 27.09.2019
Nine new professors appointed
Energy systems, cryptography and computer-aided simulation; interactions between people, animals and landscape, investigation of biosystems from the human brain to the nanometer scale: the incoming professors work in a wide range of cutting-edge research fields.

Life Sciences - Event - 26.09.2019
Congratulations to our prize winners
Congratulations to our prize winners
A highlight at the FMI Annual Meeting 2019, which has taken place last week in the Swiss Alps (Grindelwald), was the Award Ceremony: the winners of the Ed Fischer Prize for best thesis, the Max Burge

Astronomy / Space Science - Materials Science - 25.09.2019
SwissCube still going strong 10 years on
The tiny Swiss satellite, launched in September 2009, is still working. The fact that it has lasted so long is a testament to the skills of the students who built it.

Physics - Chemistry - 24.09.2019
A chip to measure vacuums
A chip to measure vacuums
Vacuums are a vital part of the processes - such as freeze-drying - used to make and preserve countless everyday items and must be measured with precision. An EPFL spin-off, Hexisense, is bringing to market a gallium nitride-based chip that can measure the quantity of certain gas molecules cheaply and with unrivalled precision.